Diabetes in African American Youth: Prevalence, Incidence, and Clinical Characteristics: the SEARCH for Diabetes in Youth Study
Overview
Authors
Affiliations
Objective: To report the prevalence and incidence of type 1 and type 2 diabetes among African American youth and to describe demographic, clinical, and behavioral characteristics.
Research Design And Methods: Data from the SEARCH for Diabetes in Youth Study, a population-based, multicenter observational study of youth with clinically diagnosed diabetes aged 0-19 years, were used to estimate the prevalence for calendar year 2001 (692 cases) and incidence based on 748 African American case subjects diagnosed in 2002-2005. Characteristics of these youth were obtained during a research visit for 436 African American youth with type 1 diabetes and 212 African American youth with type 2 diabetes.
Results: Among African American youth aged 0-9 years, prevalence (per 1,000) of type 1 diabetes was 0.57 (95% CI 0.47-0.69) and for those aged 10-19 years 2.04 (1.85-2.26). Among African American youth aged 0-9 years, annual type 1 diabetes incidence (per 100,000) was 15.7 (13.7-17.9) and for those aged 10-19 years 15.7 (13.8-17.8). A1C was >or=9.5% among 50% of youth with type 1 diabetes aged >or=15 years. Across age-groups and sex, 44.7% of African American youth with type 1 diabetes were overweight or obese. Among African American youth aged 10-19 years, prevalence (per 1,000) of type 2 diabetes was 1.06 (0.93-1.22) and annual incidence (per 100,000) was 19.0 (16.9-21.3). About 60% of African American youth with type 2 diabetes had an annual household income of <$25,000. Among those aged >or=15 years, 27.5% had an A1C >or=9.5%, 22.5% had high blood pressure, and, across subgroups of age and sex, >90% were overweight or obese.
Conclusions: Type 1 diabetes presents a serious burden among African American youth aged <10 years, and African American adolescents are impacted substantially by both type 1 and type 2 diabetes.
Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Hosseini Fard H, Ghojazadeh M Health Promot Perspect. 2024; 14(2):202-205.
PMID: 39291043 PMC: 11403338. DOI: 10.34172/hpp.43143.
Hemoglobin A1c and Type 2 Diabetes Incidence Among Adolescents With Overweight and Obesity.
Hoe F, Darbinian J, Greenspan L, Lo J JAMA Netw Open. 2024; 7(1):e2351322.
PMID: 38231515 PMC: 10794942. DOI: 10.1001/jamanetworkopen.2023.51322.
Metformin therapy in pediatric type 2 diabetes mellitus and its comorbidities: A review.
Alfaraidi H, Samaan M Front Endocrinol (Lausanne). 2023; 13:1072879.
PMID: 36814831 PMC: 9939509. DOI: 10.3389/fendo.2022.1072879.
Kanbour S, Jones M, Abusamaan M, Nass C, Everett E, Wolf R Diabetes Care. 2022; 46(1):56-64.
PMID: 36378855 PMC: 9797654. DOI: 10.2337/dc22-1055.
Suminski R, Obrusnikova I, Kelly K, Heagbetus S, Williams M J Urban Health. 2022; 99(6):1104-1114.
PMID: 36222975 PMC: 9727054. DOI: 10.1007/s11524-022-00694-8.